Literature DB >> 19303935

Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization.

Per Borghammer1, Joel Aanerud, Albert Gjedde.   

Abstract

BACKGROUND: Global mean (GM) normalization is one of the most commonly used methods of normalization in PET and SPECT group comparison studies of neurodegenerative disorders. It requires that no between-group GM difference is present, which may be strongly violated in neurodegenerative disorders. Importantly, such GM differences often elude detection due to the large intrinsic variance in absolute values of cerebral blood flow or glucose consumption. Alternative methods of normalization are needed for this type of data.
MATERIALS AND METHODS: Two types of simulation were performed using CBF images from 49 controls. Two homogeneous groups of 20 subjects were sampled repeatedly. In one group, cortical CBF was artificially decreased moderately (simulation I) or slightly (simulation II). The other group served as controls. Ratio normalization was performed using five reference regions: (1) Global mean; (2) An unbiased VOI; (3) Data-driven region extraction (Andersson); (4-5) Reference cluster methods (Yakushev et al.). Using voxel-based statistics, it was determined how much of the original signal was detected following each type of normalization.
RESULTS: For both simulations, global mean normalization performed poorly, with only a few percent of the original signal recovered. Global mean normalization moreover created artificial increases. In contrast, the data-driven reference cluster method detected 65-95% of the original signal.
CONCLUSION: In the present simulation, the reference cluster method was superior to GM normalization. We conclude that the reference cluster method will likely yield more accurate results in the study of patients with early to moderate stage neurodegenerative disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19303935     DOI: 10.1016/j.neuroimage.2009.03.021

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  25 in total

1.  Characterizing Alzheimer's disease using a hypometabolic convergence index.

Authors:  Kewei Chen; Napatkamon Ayutyanont; Jessica B S Langbaum; Adam S Fleisher; Cole Reschke; Wendy Lee; Xiaofen Liu; Dan Bandy; Gene E Alexander; Paul M Thompson; Leslie Shaw; John Q Trojanowski; Clifford R Jack; Susan M Landau; Norman L Foster; Danielle J Harvey; Michael W Weiner; Robert A Koeppe; William J Jagust; Eric M Reiman
Journal:  Neuroimage       Date:  2011-01-27       Impact factor: 6.556

2.  Brain energy metabolism and blood flow differences in healthy aging.

Authors:  Joel Aanerud; Per Borghammer; M Mallar Chakravarty; Kim Vang; Anders B Rodell; Kristjana Y Jónsdottir; Arne Møller; Mahmoud Ashkanian; Manouchehr S Vafaee; Peter Iversen; Peter Johannsen; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-29       Impact factor: 6.200

3.  Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample.

Authors:  Jerod M Rasmussen; Anita Lakatos; Theo G M van Erp; Frithjof Kruggel; David B Keator; James T Fallon; Fabio Macciardi; Steven G Potkin
Journal:  Biochim Biophys Acta       Date:  2011-09-19

4.  Metabolic connectivity as index of verbal working memory.

Authors:  Na Zou; Gael Chetelat; Mustafa G Baydogan; Jing Li; Florian U Fischer; Dmitry Titov; Juergen Dukart; Andreas Fellgiebel; Mathias Schreckenberger; Igor Yakushev
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-18       Impact factor: 6.200

5.  Uniform distributions of glucose oxidation and oxygen extraction in gray matter of normal human brain: No evidence of regional differences of aerobic glycolysis.

Authors:  Fahmeed Hyder; Peter Herman; Christopher J Bailey; Arne Møller; Ronen Globinsky; Robert K Fulbright; Douglas L Rothman; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-11       Impact factor: 6.200

6.  Optimizing PiB-PET SUVR change-over-time measurement by a large-scale analysis of longitudinal reliability, plausibility, separability, and correlation with MMSE.

Authors:  Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Nirubol Tosakulwong; Stephen D Weigand; Bradley J Kemp; Anthony J Spychalla; Prashanthi Vemuri; Ronald C Petersen; Val J Lowe; Clifford R Jack
Journal:  Neuroimage       Date:  2016-08-27       Impact factor: 6.556

7.  Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.

Authors:  Kewei Chen; Napatkamon Ayutyanont; Jessica B S Langbaum; Adam S Fleisher; Cole Reschke; Wendy Lee; Xiaofen Liu; Gene E Alexander; Dan Bandy; Richard J Caselli; Eric M Reiman
Journal:  Neuroimage       Date:  2012-02-12       Impact factor: 6.556

8.  Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease.

Authors:  Katherine R Gray; Robin Wolz; Rolf A Heckemann; Paul Aljabar; Alexander Hammers; Daniel Rueckert
Journal:  Neuroimage       Date:  2012-01-06       Impact factor: 6.556

9.  Effects of arterial transit delay on cerebral blood flow quantification using arterial spin labeling in an elderly cohort.

Authors:  Weiying Dai; Tamara Fong; Richard N Jones; Edward Marcantonio; Eva Schmitt; Sharon K Inouye; David C Alsop
Journal:  J Magn Reson Imaging       Date:  2016-07-07       Impact factor: 4.813

10.  Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.

Authors:  Auriel A Willette; Barbara B Bendlin; Erika J Starks; Alex C Birdsill; Sterling C Johnson; Bradley T Christian; Ozioma C Okonkwo; Asenath La Rue; Bruce P Hermann; Rebecca L Koscik; Erin M Jonaitis; Mark A Sager; Sanjay Asthana
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.